Cemex Down Over 7%, on Pace for Largest Percent Decrease Since March 2022 — Data Talk
Cemex SAB de CV Sponsored ADR ( CX ) is currently at $8.12, down $0.62 or 7.04%
--Would be lowest close since Jan. 25, 2024, when it closed at $8.12
--On pace for largest percent decrease since March 4, 2022, when it fell 7.06%
--Snaps a two day winning streak
--Down 1.87% month-to-date
--Up 4.84% year-to-date
--Down 70.81% from its all-time closing high of $27.84 on June 15, 2007
--Up 54.47% from 52 weeks ago (Feb. 9, 2023), when it closed at $5.26
--Down 7.04% from its 52-week closing high of $8.74 on Feb. 7, 2024
--Up 68.22% from its 52-week closing low of $4.83 on March 17, 2023
--Traded as low as $7.75; lowest intraday level since Jan. 24, 2024, when it hit $7.58
--Down 11.33% at today's intraday low; largest intraday percent decrease since June 11, 2020, when it fell as much as 12.68%
All data as of 12:05:18 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 08, 2024 12:22 ET (17:22 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks